Welcome to our dedicated page for Dss news (Ticker: DSS), a resource for investors and traders seeking the latest updates and insights on Dss stock.
DSS, Inc. (NYSE American: DSS) generates news across a wide range of sectors, reflecting its role as a multinational company with diversified business lines in packaging, biohealth innovation, financial services, alternative trading, and real estate. The company’s press releases and regulatory disclosures highlight strategic transactions, capital markets developments, operational milestones, and portfolio optimization efforts.
News about DSS often covers corporate strategy and portfolio management, including spin-offs, asset sales, and transactions involving key subsidiaries. Examples include the sale of the Celios air purification asset to Impact BioMedical Inc., as well as a definitive merger agreement under which Impact BioMedical will be acquired through a reverse merger with Dr. Ashleys Limited, resulting in a new public company. These items illustrate DSS’s stated approach of unlocking value by advancing subsidiaries toward independent public listings and other exit opportunities.
Investors and followers of DSS can also expect updates on financial performance and corporate actions. The company reports on revenue trends, cash flow improvements, debt reduction, and asset monetization, such as the sale of a real estate facility and growth in rental income. Leadership communications, including letters to shareholders and announcements of executive appointments, provide additional context on strategic priorities, cost reduction initiatives, and the focus on core growth verticals.
Because DSS has subsidiaries in securities and investment management, its news flow includes developments at entities like Sentinel Brokers Company, Inc. and AmericaFirst Funds. These updates may involve regulatory approvals, such as FINRA authorization for underwriting activities, changes to mutual fund boards, and expansion of capital markets capabilities. For a comprehensive view of DSS-related developments, readers can use this news page to follow corporate strategy, subsidiary activity, and key financial and regulatory events over time.
DSS has announced a significant acquisition by adding True Partner Capital with assets under management (AUM) of $1.7 billion into its financial services arm, DSS Securities. The acquisitions include 877 million shares from Alset EHome International in exchange for newly issued shares of DSS. Following these transactions, Alset will become the majority shareholder with a 55.52% stake. This strategic move aims to enhance growth in DSS's securities business and leverage True Partner's established platform for tailored customer solutions.
DSS, Inc. has announced its subsidiary, American Medical REIT Inc. (AMRE), acquired a 21,900 sq. ft. medical office building in Winter Haven, Florida. The primary tenant, Palm Medical Center, has a six-year lease with 1% annual rent increases. The acquisition enhances AMRE's portfolio, which now exceeds 380,000 sq. ft. of healthcare assets. Additionally, AMRE received a $4.8 million loan from American Pacific Bancorp, with detachable warrants for common stock at $10/share. This move underscores DSS's strategy in resilient medical real estate despite pandemic challenges.
Impact Biomedical, a subsidiary of DSS, has announced the development of eco-friendly bio-plastics designed to resist viruses and reduce environmental impact. Founder Daryl Thompson and his team are isolating natural compounds to enhance plastics' resistance to harmful microorganisms.
Early tests show promising anti-microbial effects against SARS-CoV-2, achieving a 90% reduction in 30 minutes and 99% in 2 hours. These bioplastics aim to address global plastic pollution and have potential applications in various sectors, with the antimicrobial market projected to reach $17.55 billion by 2026.
Value Exchange International, Inc. (OTCQB: VEII) has appointed Mr. Heng Fai Ambrose Chan to its Board of Directors as a non-executive director. Mr. Chan brings over 45 years of experience in financial restructuring and corporate transformation, having successfully restructured more than 35 companies across various sectors. Notably, five of these companies have a combined market capitalization exceeding USD 18 billion and generate over USD 1.4 billion in annual profits. This appointment is expected to enhance the company's leadership and strategic direction.
DSS, Inc. has announced the near completion of a 105,000 sq. ft. facility for its subsidiary, Premier Packaging Corporation, located in Henrietta, NY. This expansion, scheduled to start operations on February 1, 2022, more than doubles Premier's existing capacity. The investment includes approximately $12 million in CAPEX, aimed at improving production efficiency and increasing staffing by over 50%. Premier specializes in sustainable fiber-based packaging solutions, targeting a growing customer demand while minimizing environmental impacts.
DSS, Inc. (NYSE American: DSS) announced that its subsidiary, American Pacific Bancorp (APB), has issued nearly $20 million in new loans since September 2021. CEO Frank D. Heuszel highlighted the diversified loan portfolio, which includes commercial real estate financing and equipment loans. APB targets businesses with annual revenues between $5 million to over $50 million across various sectors. DSS holds over 50% of APB's shares, with plans to expand its lending network and serve clients globally, particularly in underserved markets.
DSS, Inc. (NYSE American: DSS) has opened a new office in Sacramento, California, serving as the headquarters for DSS Wealth Management and DSS AmericaFirst Quantitative Funds. This strategic move is expected to enhance sales and marketing efforts, capitalizing on strong growth potential in the wealth management sector. DSS AmericaFirst offers various mutual funds aiming to outperform benchmarks through quantitative strategies. The firm continues to diversify its portfolio to drive profitability across several high-growth sectors, including blockchain security and renewable energy.
DSS, a multinational company, announced its participation in the Emerging Growth Conference on December 8, 2021, at 2:30 p.m. ET. The event allows for real-time interaction between investors and the company's management team, including CEO Frank D. Heuszel, COO Jason Grady, and CFO Todd Macko. Attendees can ask questions following the presentation. Registration is required in advance, with a recorded version available later for those unable to attend live. DSS operates in sectors such as blockchain security, healthcare, and renewable energy.
On November 30, 2021, DSS announced the launch of DSS AmericaFirst Quantitative Funds, a suite of mutual funds managed by DSS Wealth Management. The funds include four offerings: Income Trends Fund, Defensive Growth Fund, Risk-On Risk-Off Fund, and Large Cap Buyback Fund, each aiming to outperform benchmark indices using a quantitative approach. CEO Frank D. Heuszel emphasized the growth potential and innovative strategies behind the funds. DSS Wealth Management serves as the registered investment advisor to the funds, earning fees based on average daily net assets.
DSS, Inc. (NYSE American: DSS) announced that its subsidiary, American Medical REIT Inc. (AMRE), has acquired three hospitals in Texas and Pennsylvania for $62 million. Currently under an 18-year lease with LifeCare Hospitals, these facilities offer a combined capacity of 195 beds and span approximately 320,000 square feet. The acquisition aims to expand AMRE's portfolio and create sustainable dividends for shareholders. DSS CEO Frank D. Heuszel emphasized the acquisition's strategic importance in enhancing their real estate operations in the resilient medical sector.
FAQ
What is the current stock price of Dss (DSS)?
What is the market cap of Dss (DSS)?
